Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 168

1.

Borrelia miyamotoi in vectors and hosts in The Netherlands.

Wagemakers A, Jahfari S, de Wever B, Spanjaard L, Starink MV, de Vries HJC, Sprong H, Hovius JW.

Ticks Tick Borne Dis. 2017 Mar;8(3):370-374. doi: 10.1016/j.ttbdis.2016.12.012. Epub 2016 Dec 30.

2.

Imbalanced presence of Borrelia burgdorferi s.l. multilocus sequence types in clinical manifestations of Lyme borreliosis.

Coipan EC, Jahfari S, Fonville M, Oei GA, Spanjaard L, Takumi K, Hovius JW, Sprong H.

Infect Genet Evol. 2016 Aug;42:66-76. doi: 10.1016/j.meegid.2016.04.019. Epub 2016 Apr 25.

3.

Haematological malignancy in the intensive care unit: microbiology results and mortality.

van Beers EJ, Müller MC, Vlaar AP, Spanjaard L, van den Bergh WM; HEMA-ICU Study Group.

Eur J Haematol. 2016 Sep;97(3):271-7. doi: 10.1111/ejh.12721. Epub 2016 Feb 4.

PMID:
26676382
4.

Risk factors for sporadic listeriosis in the Netherlands, 2008 to 2013.

Friesema IH, Kuiling S, van der Ende A, Heck ME, Spanjaard L, van Pelt W.

Euro Surveill. 2015 Aug 6;20(31). pii: 21199.

5.

Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trial.

Schoot RA, van Ommen CH, Stijnen T, Tissing WJ, Michiels E, Abbink FC, Raphael MF, Heij HA, Lieverst JA, Spanjaard L, Zwaan CM, Caron HN, van de Wetering MD.

Eur J Cancer. 2015 Sep;51(14):2031-8. doi: 10.1016/j.ejca.2015.06.126. Epub 2015 Jul 15.

PMID:
26188849
6.

Disease Burden of Invasive Meningococcal Disease in the Netherlands Between June 1999 and June 2011: A Subjective Role for Serogroup and Clonal Complex.

Stoof SP, Rodenburg GD, Knol MJ, Rümke LW, Bovenkerk S, Berbers GA, Spanjaard L, van der Ende A, Sanders EA.

Clin Infect Dis. 2015 Oct 15;61(8):1281-92. doi: 10.1093/cid/civ506. Epub 2015 Jun 29.

PMID:
26123933
7.

Ticking the right boxes: classification of patients suspected of Lyme borreliosis at an academic referral center in the Netherlands.

Coumou J, Herkes EA, Brouwer MC, van de Beek D, Tas SW, Casteelen G, van Vugt M, Starink MV, de Vries HJ, de Wever B, Spanjaard L, Hovius JW.

Clin Microbiol Infect. 2015 Apr;21(4):368.e11-20. doi: 10.1016/j.cmi.2014.11.014. Epub 2014 Nov 22.

8.

The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial.

Westendorp WF, Vermeij JD, Zock E, Hooijenga IJ, Kruyt ND, Bosboom HJ, Kwa VI, Weisfelt M, Remmers MJ, ten Houten R, Schreuder AH, Vermeer SE, van Dijk EJ, Dippel DW, Dijkgraaf MG, Spanjaard L, Vermeulen M, van der Poll T, Prins JM, Vermeij FH, Roos YB, Kleyweg RP, Kerkhoff H, Brouwer MC, Zwinderman AH, van de Beek D, Nederkoorn PJ; PASS investigators.

Lancet. 2015 Apr 18;385(9977):1519-26. doi: 10.1016/S0140-6736(14)62456-9. Epub 2015 Jan 20.

PMID:
25612858
9.

Fusobacterium necrophorum, an emerging pathogen of otogenic and paranasal infections?

Creemers-Schild D, Gronthoud F, Spanjaard L, Visser LG, Brouwer CN, Kuijper EJ.

New Microbes New Infect. 2014 May;2(3):52-7. doi: 10.1002/nmi2.39. Epub 2014 Mar 25.

10.

Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data.

Bijlsma MW, Bekker V, Brouwer MC, Spanjaard L, van de Beek D, van der Ende A.

Lancet Infect Dis. 2014 Sep;14(9):805-12. doi: 10.1016/S1473-3099(14)70806-0. Epub 2014 Aug 4.

PMID:
25104306
11.

A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.

Bijlsma MW, Brouwer MC, Spanjaard L, van de Beek D, van der Ende A.

Clin Infect Dis. 2014 Nov 1;59(9):1216-21. doi: 10.1093/cid/ciu601. Epub 2014 Jul 28.

PMID:
25069869
12.

Update on the Preventive Antibiotics in Stroke Study (PASS): a randomised controlled phase 3 clinical trial.

Westendorp WF, Vermeij JD, van Geloven N, Dippel DW, Dijkgraaf MG, van der Poll T, Prins JM, Spanjaard L, Vermeij FH, Nederkoorn PJ, van de Beek D.

Trials. 2014 Apr 21;15:133. doi: 10.1186/1745-6215-15-133.

13.

Unsuccessful validation of 2004 model for predicting academic or behavioural limitations after childhood bacterial meningitis.

de Jonge RC, Sanders MS, Terwee CB, Heymans MW, Gemke RJ, Koomen I, Spanjaard L, van Furth AM.

Acta Paediatr. 2013 Dec;102(12):e553-9. doi: 10.1111/apa.12407. Epub 2013 Sep 21.

PMID:
24033640
14.

Addition of host genetic variants in a prediction rule for post meningitis hearing loss in childhood: a model updating study.

Sanders MS, de Jonge RC, Terwee CB, Heymans MW, Koomen I, Ouburg S, Spanjaard L, Morré SA, van Furth AM.

BMC Infect Dis. 2013 Jul 23;13:340. doi: 10.1186/1471-2334-13-340.

15.

Reduction of unnecessary use of indwelling urinary catheters.

Janzen J, Buurman BM, Spanjaard L, de Reijke TM, Goossens A, Geerlings SE.

BMJ Qual Saf. 2013 Dec;22(12):984-8. doi: 10.1136/bmjqs-2013-001908. Epub 2013 Jun 6.

PMID:
23744536
16.

Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns.

Miedema KG, Winter RH, Ammann RA, Droz S, Spanjaard L, de Bont ES, Kamps WA, van de Wetering MD, Tissing WJ.

Support Care Cancer. 2013 Sep;21(9):2417-26. doi: 10.1007/s00520-013-1797-4. Epub 2013 Apr 12.

PMID:
23579946
17.

Independent validation of an existing model enables prediction of hearing loss after childhood bacterial meningitis.

de Jonge RC, Sanders MS, Terwee CB, Heymans MW, Gemke RJ, Koomen I, Spanjaard L, van Furth AM.

PLoS One. 2013;8(3):e58707. doi: 10.1371/journal.pone.0058707. Epub 2013 Mar 11.

18.

Neonatal gram negative and Candida sepsis survival and neurodevelopmental outcome at the corrected age of 24 months.

de Haan TR, Beckers L, de Jonge RC, Spanjaard L, van Toledo L, Pajkrt D, van Wassenaer-Leemhuis AG, van der Lee JH.

PLoS One. 2013;8(3):e59214. doi: 10.1371/journal.pone.0059214. Epub 2013 Mar 18.

19.

[Treatment of recurrent furunculosis].

Engelhard EA, Spanjaard L, Stijnis CK.

Ned Tijdschr Geneeskd. 2013;157(5):A5548. Review. Dutch.

PMID:
23369819
20.

Extensive genetic diversity within the Dutch clinical Cryptococcus neoformans population.

Hagen F, Illnait-Zaragozí MT, Meis JF, Chew WH, Curfs-Breuker I, Mouton JW, Hoepelman AI, Spanjaard L, Verweij PE, Kampinga GA, Kuijper EJ, Boekhout T, Klaassen CH.

J Clin Microbiol. 2012 Jun;50(6):1918-26. doi: 10.1128/JCM.06750-11. Epub 2012 Mar 21.

21.

[An infant with meningitis caused by resistant pneumococcus: infection despite vaccination].

van der Meer H, van Zwol A, Spanjaard L, van Furth M.

Ned Tijdschr Geneeskd. 2012;156(1):A3806. Dutch.

PMID:
22217305
22.

Fatal outcome of Bacillus cereus septicaemia.

Lede I, Vlaar A, Roosendaal R, Geerlings S, Spanjaard L.

Neth J Med. 2011 Nov-Dec;69(11):514-6.

23.

New England souvenirs.

van Vugt M, Wetsteyn JC, Haverkort M, Kolader M, Verhaar N, Spanjaard L, Grobusch MP, Bart A, van Gool T.

J Travel Med. 2011 Nov-Dec;18(6):425-6. doi: 10.1111/j.1708-8305.2011.00562.x. Epub 2011 Oct 12.

24.

Associations between multidrug resistance, plasmid content, and virulence potential among extraintestinal pathogenic and commensal Escherichia coli from humans and poultry.

Johnson TJ, Logue CM, Johnson JR, Kuskowski MA, Sherwood JS, Barnes HJ, DebRoy C, Wannemuehler YM, Obata-Yasuoka M, Spanjaard L, Nolan LK.

Foodborne Pathog Dis. 2012 Jan;9(1):37-46. doi: 10.1089/fpd.2011.0961. Epub 2011 Oct 11.

25.

Eradication of carriage with methicillin-resistant Staphylococcus aureus: effectiveness of a national guideline.

Ammerlaan HS, Kluytmans JA, Berkhout H, Buiting A, de Brauwer EI, van den Broek PJ, van Gelderen P, Leenders SA, Ott A, Richter C, Spanjaard L, Spijkerman IJ, van Tiel FH, Voorn GP, Wulf MW, van Zeijl J, Troelstra A, Bonten MJ; MRSA Eradication Study Group.

J Antimicrob Chemother. 2011 Oct;66(10):2409-17. doi: 10.1093/jac/dkr243. Epub 2011 Jun 30.

PMID:
21719473
26.

Eradication of carriage with methicillin-resistant Staphylococcus aureus: determinants of treatment failure.

Ammerlaan HS, Kluytmans JA, Berkhout H, Buiting A, de Brauwer EI, van den Broek PJ, van Gelderen P, Leenders SA, Ott A, Richter C, Spanjaard L, Spijkerman IJ, van Tiel FH, Voorn GP, Wulf MW, van Zeijl J, Troelstra A, Bonten MJ; MRSA Eradication Study Group.

J Antimicrob Chemother. 2011 Oct;66(10):2418-24. doi: 10.1093/jac/dkr250. Epub 2011 Jun 30.

PMID:
21719471
27.

The additional value of blood culture bottles in the diagnosis of endophthalmitis.

Tan HS, Ghyczy-Carlborg EA, Spanjaard L, de Smet MD.

Eye (Lond). 2011 Aug;25(8):1069-73. doi: 10.1038/eye.2011.142. Epub 2011 Jun 17.

28.

Nontypeable Haemophilus influenzae invasive disease in The Netherlands: a retrospective surveillance study 2001-2008.

van Wessel K, Rodenburg GD, Veenhoven RH, Spanjaard L, van der Ende A, Sanders EA.

Clin Infect Dis. 2011 Jul 1;53(1):e1-7. doi: 10.1093/cid/cir268.

PMID:
21653293
29.

Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy.

Bouts A, Monnens L, Davin JC, Struijk G, Spanjaard L.

Pediatr Nephrol. 2011 Oct;26(10):1919-20. doi: 10.1007/s00467-011-1929-3. Epub 2011 Jun 5. No abstract available.

30.

Highly resistant gram-negative microorganisms: incidence density and occurrence of nosocomial transmission (TRIANGLe Study).

Willemsen I, Elberts S, Verhulst C, Rijnsburger M, Filius M, Savelkoul P, Kluytmans J, Lommerse E, Spanjaard L, Vlaminckx B, Vos A, Wulf M, Vos M, Wintermans R, Andriesse G, van Zeijl J, van der Vorm E, Buiting A, Sturm P, Blok H, Troelstra A, Kaiser A, Vandenbroucke-Grauls C.

Infect Control Hosp Epidemiol. 2011 Apr;32(4):333-41. doi: 10.1086/658941.

PMID:
21460484
31.

Association of chronic meningococcemia with infection by meningococci with underacylated lipopolysaccharide.

Brouwer MC, Spanjaard L, Prins JM, van der Ley P, van de Beek D, van der Ende A.

J Infect. 2011 Jun;62(6):479-83. doi: 10.1016/j.jinf.2011.03.010. Epub 2011 Mar 31.

PMID:
21459106
32.

Preventive antibiotics in stroke study: rationale and protocol for a randomised trial.

Nederkoorn PJ, Westendorp WF, Hooijenga IJ, de Haan RJ, Dippel DW, Vermeij FH, Dijkgraaf MG, Prins JM, Spanjaard L, van de Beek D.

Int J Stroke. 2011 Apr;6(2):159-63. doi: 10.1111/j.1747-4949.2010.00555.x. Epub 2010 Dec 16.

PMID:
21371281
33.

Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis.

Brouwer MC, Heckenberg SG, de Gans J, Spanjaard L, Reitsma JB, van de Beek D.

Neurology. 2010 Oct 26;75(17):1533-9. doi: 10.1212/WNL.0b013e3181f96297. Epub 2010 Sep 29.

PMID:
20881273
34.

Simulated effect of pneumococcal vaccination in the Netherlands on existing rules constructed in a non-vaccinated cohort predicting sequelae after bacterial meningitis.

Commandeur AE, de Jonge RC, Koomen I, Spanjaard L, van Furth AM, Terwee CB.

BMC Infect Dis. 2010 Sep 3;10:259. doi: 10.1186/1471-2334-10-259.

35.

Clindamycin-resistant Staphylococcus aureus in foot ulcers of patients with diabetes.

Regeer MV, van Bon AC, Spanjaard L, Busch-Westbroek TE, van Schie CH, Geerlings SE, Devries JH.

J Infect. 2010 Jul;61(2):192-5. doi: 10.1016/j.jinf.2010.05.006. Epub 2010 Jun 9. No abstract available.

PMID:
20540963
36.

Effects of pneumococcal conjugate vaccine 2 years after its introduction, the Netherlands.

Rodenburg GD, de Greeff SC, Jansen AG, de Melker HE, Schouls LM, Hak E, Spanjaard L, Sanders EA, van der Ende A.

Emerg Infect Dis. 2010 May;16(5):816-23. doi: 10.3201/eid1605.091223.

37.

Kytococcus schroeteri pneumonia in two patients with a hematological malignancy.

Hodiamont CJ, Huisman C, Spanjaard L, van Ketel RJ.

Infection. 2010 Apr;38(2):138-40. doi: 10.1007/s15010-009-9295-4. Epub 2010 Mar 5.

PMID:
20213285
38.

Preventive antibiotics for infections in acute stroke: a systematic review and meta-analysis.

van de Beek D, Wijdicks EF, Vermeij FH, de Haan RJ, Prins JM, Spanjaard L, Dippel DW, Nederkoorn PJ.

Arch Neurol. 2009 Sep;66(9):1076-81. doi: 10.1001/archneurol.2009.176. Review.

PMID:
19752296
39.

Haemophilus influenzae serotype b vaccine failure: what is the significance of antibody levels?

Spanjaard L, Rijkers GT.

Clin Infect Dis. 2009 Aug 1;49(3):381-2. doi: 10.1086/600293. No abstract available.

PMID:
19580417
40.

Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome.

Jansen AG, Rodenburg GD, van der Ende A, van Alphen L, Veenhoven RH, Spanjaard L, Sanders EA, Hak E.

Clin Infect Dis. 2009 Jul 15;49(2):e23-9. doi: 10.1086/600045.

PMID:
19522653
41.

Invasive pneumococcal disease in the Netherlands: Syndromes, outcome and potential vaccine benefits.

Jansen AG, Rodenburg GD, de Greeff SC, Hak E, Veenhoven RH, Spanjaard L, Schouls LM, Sanders EA, van der Ende A.

Vaccine. 2009 Apr 14;27(17):2394-401. doi: 10.1016/j.vaccine.2009.01.127. Epub 2009 Feb 6.

PMID:
19428856
42.

Hyperglycemia in bacterial meningitis: a prospective cohort study.

Schut ES, Westendorp WF, de Gans J, Kruyt ND, Spanjaard L, Reitsma JB, van de Beek D.

BMC Infect Dis. 2009 May 8;9:57. doi: 10.1186/1471-2334-9-57.

43.

Community acquired Staphylococcus aureus meningitis in adults.

Brouwer MC, Keizerweerd GD, De Gans J, Spanjaard L, Van De Beek D.

Scand J Infect Dis. 2009;41(5):375-7. doi: 10.1080/00365540902744766.

PMID:
19177261
44.

Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens.

Johnson TJ, Wannemuehler Y, Johnson SJ, Stell AL, Doetkott C, Johnson JR, Kim KS, Spanjaard L, Nolan LK.

Appl Environ Microbiol. 2008 Nov;74(22):7043-50. doi: 10.1128/AEM.01395-08. Epub 2008 Sep 26.

45.

Epidemiologic and microbiologic characteristics of recurrent bacterial and fungal meningitis in the Netherlands, 1988-2005.

van Driel JJ, Bekker V, Spanjaard L, van der Ende A, Kuijpers TW.

Clin Infect Dis. 2008 Sep 1;47(5):e42-51. doi: 10.1086/590251.

PMID:
18643757
46.

Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study.

Heckenberg SG, de Gans J, Brouwer MC, Weisfelt M, Piet JR, Spanjaard L, van der Ende A, van de Beek D.

Medicine (Baltimore). 2008 Jul;87(4):185-92. doi: 10.1097/MD.0b013e318180a6b4.

47.

Streptococcus suis meningitis in the Netherlands.

van de Beek D, Spanjaard L, de Gans J.

J Infect. 2008 Aug;57(2):158-61. doi: 10.1016/j.jinf.2008.04.009. Epub 2008 Jun 6.

PMID:
18538852
48.

Pre-admission clinical course of meningococcal disease and opportunities for the earlier start of appropriate intervention: a prospective epidemiological study on 752 patients in the Netherlands, 2003-2005.

de Greeff SC, de Melker HE, Schouls LM, Spanjaard L, van Deuren M.

Eur J Clin Microbiol Infect Dis. 2008 Oct;27(10):985-92. doi: 10.1007/s10096-008-0535-1. Epub 2008 May 21.

PMID:
18493804
49.

Fatal case of human rabies (Duvenhage virus) from a bat in Kenya: The Netherlands, December 2007.

van Thiel PP, van den Hoek JA, Eftimov F, Tepaske R, Zaaijer HJ, Spanjaard L, de Boer HE, van Doornum GJ, Schutten M, Osterhaus A, Kager PA.

Euro Surveill. 2008 Jan 10;13(2). pii: 8007. No abstract available.

50.

Seizures in adults with bacterial meningitis.

Zoons E, Weisfelt M, de Gans J, Spanjaard L, Koelman JH, Reitsma JB, van de Beek D.

Neurology. 2008 May 27;70(22 Pt 2):2109-15. doi: 10.1212/01.wnl.0000288178.91614.5d. Epub 2008 Feb 27.

PMID:
18305232

Supplemental Content

Loading ...
Support Center